“I cannot check you in, but that is not BA’s problem.” This was the infuriating answer I got from a flight attendant with the captivating charm of the Wandsworth prison …
I apologize for my strong and passionate reaction to the new Medseek facebook page. In case you missed Phil Baumann’s or Eileen O’Brien ...
The FDA hearing on social media took place almost a month ago already and a lof of ink (or pixel for that matter) has flown since on what was presente ...
Researching the latest EU commission view point on social media, I came across this very upsetting conclusion from a review on the state of patient in ...
Exactly 20 years ago today, one of the most horrific monuments of the cold war came down: the Berlin wall. I remember strolling through East and West Berlin some days ...
Jon over at dose of digital just wrote a great post asking Can Social Media Improve Your Health or Change Your Life? “Of course it can!“ was my immediate thought, ...
Lately, I witnessed the start of a fascinating dialog between pharma, medical device companies and diabetes bloggers. Roche, for example, just sponsored the first diabetes blog summit bringing together the ...
Last Friday, I asked you to recommend your favourite pharma twitter accounts under the #followpharma hashtag. I promised that in return for your participation, I would summarize, analyze and consolidate ...
A fascinating discussion popped-up today around strategies and tactics that pharma should use to engage with social media. Johnathan over at dose of digital started this discussion with this list ...
Patientslikeme announced last week: “ a pilot program in our multiple sclerosis community which helps patients submit treatment-related adverse events directly to the The U.S. Food and Drug Administration (FDA) ...
